|
|
|
For other announcements of interest to the medical community, choose a subcategory from the menu on the left.
|
|
|
|
|
A Web-based course for healthcare providers who are interested in becoming clinical trials investigators and including cancer clinical trials in their practice. |
|
|
|
|
Expert faculty members present the most clinically relevant data from the 12th International Myeloma Workshop in CME-certified video modules. Jointly sponsored by Postgraduate Institute for Medicine, the International Myeloma Foundation, and Clinical Care Options, LLC.
|
|
|
|
|
This quarterly publication features up-to-date information on research advances and new therapies. |
|
|
|
|
This year at the International Myeloma Workshop, our own Dr. Durie won the Waldenströms Award for 40 years of excellence in myeloma. As part of the award, he was invited to deliver a lecture. Introduced by Dr. Kyle, this is the webcast of that lecture. |
|
|
|
|
Free-floating messages in the bloodstream could soon provide a unique window into the body. Researchers worldwide are racing to decipher circulating genetic material for better ways to diagnose disease, monitor pregnancy, and even improve food safety. |
|
|
|
|
The International Myeloma Working Group is made up of 90 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects with a goal to improve myeloma treatment options and diagnostic systems. The serum-free light chain analysis guidelines are the result of this collaboration. |
|
|
|
|
International Myeloma Foundation
Highlights from the 50th Annual Meeting
of the American Society for Hematology (ASH) held in San Francisco, California,
December 5–9, 2008. |
|
|
|
|
|
Will Study Circulating DNA as a Marker for and Potential Cause of Disease Recurrence |
|
|
|
|
In the Mayo Clinic Proceedings, IMF Scientific Advisor, Dr. Vincent Rajkumar writes that "cure vs control" is the dominant philosophical difference behind many of the strategies, trials, and debates related to the management of myeloma. |
|
|
|
|
News from the 2008 ASCO Meeting Compiled by Lynne Lederman, PhD |
|
|
print
back to top